Skip to content

Profiling for novel proteomics biomarkers in neurodevelopmental disorders.

by Ed Dudley, Frank Hässler, Johannes Thome
Expert review of proteomics ()
Get full text at journal

Abstract

Protein biomarker discovery from biological fluids, such as serum, has been widely applied to disorders such as cancer and has more recently also been utilized in neuro-psychiatric disorders with relatively clear biological causes, such as Alzheimer's disease and schizophrenia. The application of the associated technologies for the identification of protein biomarker signatures in neurodevelopmental disorders, such as autism spectrum disorder and attention deficit hyperactivity disorder, is comparatively less well established. The aim of this article is to provide an overview of the various protocols available for such analysis, discuss reports in which these techniques have been previously applied in biomarker discovery/validation in neurodevelopmental disorders, and consider the future development of this area of research.

Cite this document (BETA)

Readership Statistics

16 Readers on Mendeley
by Discipline
 
44% Medicine and Dentistry
 
19% Agricultural and Biological Sciences
 
13% Computer Science
by Academic Status
 
25% Researcher
 
25% Professor
 
19% Other
by Country
 
13% United States

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in